Legal Opinion
Janssen Pharmaceutica, NV v. Apotex, Inc.
Court of Appeals for the Federal Circuit
Decided September 4, 2008No. 2008-1062PublishedCited by 32 opinions
1Opinion of the Court
MOORE, Circuit Judge.
Defendant-Appellant Apotex, Inc. (Apotex) appeals the order of the United States District Court for the District of New Jersey dismissing its declaratory judgment action for noninfringement against Plaintiffs-Appellees Janssen Pharmaceutica, N.V. and Janssen, L.P. (collectively Janssen). We affirm.
BACKGROUND
I
This case arises under the Hatch-Wax-man Act (Act), 1 which governs the Food and Drug Administration’s (FDA) approval of new and generic drugs. The goal of the Act is to better balance two competing interests in the pharmaceutical industry: “(1) inducing pioneering…
2Cases cited16 opinions
- Steffel v. ThompsonSupreme Court of the United States · 1974
- Caterpillar Inc. v. LewisSupreme Court of the United States · 1996
- MedImmune, Inc. v. Genentech, Inc.Supreme Court of the United States · 2007
- Eli Lilly & Co. v. Medtronic, Inc.Supreme Court of the United States · 1990
- Prasco, LLC v. Medicis Pharmaceutical Corp.Court of Appeals for the Federal Circuit · 2008
11 more not listed; retrieve them via the Exa API.
3Cited by32 opinions
- King Pharmaceuticals, Inc. v. Eon Labels, IncCourt of Appeals for the Federal Circuit · 2010
- In re Opana ER Antritrust LitigationDistrict Court, N.D. Illinois · 2016
- Sanofi-Aventis U.S., LLC v. Fresenius Kabi USA, LLCCourt of Appeals for the Federal Circuit · 2019
- Amerigen Pharmaceuticals v. Ucb Pharma GmbhCourt of Appeals for the Federal Circuit · 2019
- Mike's Train House, Inc. v. BROADWAY LTD. IMPORTSDistrict Court, D. Maryland · 2010
27 more not listed; retrieve them via the Exa API.